Close Menu

Life After Genentech

David Ebersman, who was the chief financial officer at Genentech until it was acquired by Roche, has a new gig. According to TechCrunch, he is the new CFO of Facebook, replacing Gideon Yu. Ebersman had been at Genentech for 15 years. He will formally start at Facebook in September. Do we see a social networking angle for pharmaceutical development in our future?

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.